Melatonin and its analog 5-methoxycarbonylamino-N-acetyltryptamine potentiate adrenergic receptor-mediated ocular hypotensive effects in rabbits: significance for …

A Crooke, F Huete-Toral, A Martínez-Águila… - … of Pharmacology and …, 2013 - ASPET
Melatonin is currently considered a promising drug for glaucoma treatment because of its
ocular hypotensive and neuroprotective effects. We have investigated the effect of melatonin …
被引用次数：41 相关文章

Melatonin and its analog 5-methoxycarbonylamino-N-acetyltryptamine potentiate adrenergic receptor-mediated ocular hypotensive effects in rabbits: significance for …

A Crooke, F Huete-Toral… - The Journal of …, 2013 - pubmed.ncbi.nlm.nih.gov
Melatonin is currently considered a promising drug for glaucoma treatment because of its
ocular hypotensive and neuroprotective effects. We have investigated the effect of melatonin …

Melatonin and its analog 5-methoxycarbonylamino-N-acetyltryptamine potentiate adrenergic receptor-mediated ocular hypotensive effects in rabbits: significance for …

A Crooke, F Huete-Toral, A Martínez-Águila… - The Journal of …, 2013 - europepmc.org
Melatonin is currently considered a promising drug for glaucoma treatment because of its
ocular hypotensive and neuroprotective effects. We have investigated the effect of melatonin …

[引用][C] Melatonin and its analog 5-methoxycarbonylamino-N-acetyltryptamine potentiate adrenergic receptor-mediated ocular hypotensive effects in rabbits …

A Crooke, F Huete-Toral… - Journal of …, 2013 - produccioncientifica.ucm.es
[PDF] researchgate.net

[PDF][PDF] Melatonin and Its Analog 5-Methoxycarbonylamino-N-Acetyltryptamine Potentiate Adrenergic Receptor-Mediated Ocular Hypotensive Effects in Rabbits …

A Crooke, F Huete-Toral… - THE JOURNAL OF …, 2013 - researchgate.net
Melatonin is currently considered a promising drug for glaucoma treatment because of its
ocular hypotensive and neuroprotective effects. We have investigated the effect of melatonin …
[PDF] academia.edu

[PDF][PDF] Melatonin and Its Analog 5-Methoxycarbonylamino-N-Acetyltryptamine Potentiate Adrenergic Receptor-Mediated Ocular Hypotensive Effects in Rabbits …

A Crooke, F Huete-Toral, A Martínez-Águila… - THE JOURNAL OF …, 2013 - academia.edu
Melatonin is currently considered a promising drug for glaucoma treatment because of its
ocular hypotensive and neuroprotective effects. We have investigated the effect of melatonin …
[PDF] academia.edu

[PDF][PDF] Melatonin and Its Analog 5-Methoxycarbonylamino-N-Acetyltryptamine Potentiate Adrenergic Receptor-Mediated Ocular Hypotensive Effects in Rabbits …

A Crooke, F Huete-Toral, A Martínez-Águila… - THE JOURNAL OF …, 2013 - academia.edu
Melatonin is currently considered a promising drug for glaucoma treatment because of its
ocular hypotensive and neuroprotective effects. We have investigated the effect of melatonin …